These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 445333)

  • 1. Metabolic changes following the intravenous infusion of Corynebacterium parvum in man.
    Royle G; Gill PG
    Cancer; 1979 Apr; 43(4):1328-30. PubMed ID: 445333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man.
    Wan HH; Thatcher N; Mullen PW; Smith GN; Wilkinson PM
    Br J Cancer; 1979 Apr; 39(4):441-4. PubMed ID: 444399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum.
    Soyka LF; Stephens CC; MacPherson BR; Foster RS
    Int J Immunopharmacol; 1979; 1(2):101-12. PubMed ID: 551956
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Side-effects of intravenous Corynebacterium parvum.
    Hamilton DN
    Lancet; 1975 Dec; 2(7947):1263. PubMed ID: 53755
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary considerations on the intravenous use of Corynebacterium parvum in the treatment of solid neoplasms].
    Scheinberg MA; Sartori JP; de Pinho JG
    AMB Rev Assoc Med Bras; 1979 Apr; 25(4):139-40. PubMed ID: 315598
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Corynebacterium parvum and anaesthetics.
    Mosedale B; Smith MA
    Lancet; 1975 Jan; 1(7899):168. PubMed ID: 46085
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Corynebacterium parvum on liver proliferation and regeneration.
    Fisher B; Gebhardt MC; Saffer EA; Fisher ER
    Cancer Res; 1979 Apr; 39(4):1361-8. PubMed ID: 421219
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Corynebacterium parvum and anaesthetics.
    Farquhar D; Loo TL; Reed R; Luna M
    Lancet; 1975 Apr; 1(7912):914. PubMed ID: 47551
    [No Abstract]   [Full Text] [Related]  

  • 9. Corynebacterium parvum toxicity.
    Sexauer CL; Nitschke R; Humphrey GB
    Lancet; 1976 Jul; 2(7978):199. PubMed ID: 73819
    [No Abstract]   [Full Text] [Related]  

  • 10. Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers.
    Sawyer RT; Moon RJ; Beneke ES
    Infect Immun; 1981 May; 32(2):945-50. PubMed ID: 7019084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Corynebacterium parvum vaccine on drug metabolism in the mouse.
    Macnee CM; Nimmo-Smith RH
    Dev Biol Stand; 1977 Apr 13-15; 38():427-30. PubMed ID: 608533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in blood glucose levels in relation to blood ketone body ratio following hypertonic glucose infusion in 70% hepatectomized rabbits.
    Nakatani T; Yasuda K; Ozawa K; Tobe T
    Eur Surg Res; 1984; 16(5):303-11. PubMed ID: 6468465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complications of intravenous Corynebacterium parvum infusion.
    Gill PG; Morris PJ; Kettlewell M
    Clin Exp Immunol; 1977 Nov; 30(2):229-32. PubMed ID: 606444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary observations on the use of Corynebacterium parvum in patients with primary intracranial tumors: effect on intracranial pressure.
    Selker RG; Wolmark N; Fisher B; Moore P
    J Surg Oncol; 1978; 10(4):299-303. PubMed ID: 692136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival in severely burned animals using intravenous Corynebacterium parvum vaccine post injury.
    Stinnett JD; Alexander JW; Morris MJ; Dreffer RL; Craycraft TK; Anderson PE; Ogle CK; MacMillan BG
    Surgery; 1981 Feb; 89(2):237-42. PubMed ID: 7455909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ distribution of Corynebacterium parvum labeled with iodine-125.
    Dimitrov NV; Greenberg CS; Denny T
    J Natl Cancer Inst; 1977 Feb; 58(2):287-94. PubMed ID: 833877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver function and lactate metabolism in the ill surgical patient.
    Royle G; Kettlewell M
    Br J Surg; 1978 Sep; 65(9):661-2. PubMed ID: 698542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
    Fisher B; Wolmark N; Saffer E; Fisher ER
    Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of low-dose incremental insulin infusion in diabetic man.
    Hale PJ; Black E; Nattrass M
    Horm Metab Res; 1986 Feb; 18(2):129-33. PubMed ID: 3516823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.